Epidemiology of Osteoporosis in Rheumatic Diseases

Rheumatic Disease Clinics of North America

Volumn 32, Issue 4, 2006, Pages 631-658

  Sinigaglia, Luigi ^a   Varenna, Massimo ^a   Girasole, Giuseppe ^b   Bianchi, Gerolamo ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale La Colletta   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; AZATHIOPRINE; CALCIUM; COLLAGEN TYPE 1; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE; PREDNISONE; TESTOSTERONE; VITAMIN D;

ANKYLOSING SPONDYLITIS; BONE DENSITOMETRY; BONE DENSITY; CORTICOSTEROID THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HUMAN; INFLAMMATION; OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; QUALITY OF LIFE; REVIEW; RHEUMATIC DISEASE; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; SIDE EFFECT; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VERTEBRA FRACTURE; FRACTURE;

ARTHRITIS, RHEUMATOID; FRACTURES, BONE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OSTEOPOROSIS; RHEUMATIC DISEASES;

EID: 34247095201     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2006.07.002     Document Type: Review

References (144)

1. Solomon D.H., Katz J.N., Jacobs J.P., et al. Management of glucocorticoid induced osteoporosis in rheumatoid arthritis. Arthritis Rheum 46 (2002) 3136-3142
2. Barwell R. Diseases of joints (1865), Hardwicke, London
3. Deodhar A.A., and Woolf A.D. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35 (1996) 309-322
4. Sinigaglia L., Nervetti A., Mela Q., et al. A multicenter cross-sectional study on bone mineral density in rheumatoid arthritis. J Rheumatol 27 (2000) 2582-2589
5. Haugeberg G., Uhlig T., Falch J.A., et al. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis. Arthritis Rheum 43 (2000) 522-530
6. Stafford L., Bleasel J., Giles A., et al. Androgen deficiency and bone mineral density in men with rheumatoid arthritis. J Rheumatol 27 (2000) 2786-2790
7. Tengstrand B., and Hafstrom I. Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones. J Rheumatol 29 (2002) 2299-2305
8. Haugeberg G., Uhlig T., Falch J.A., et al. Reduced bone mineral density in male rheumatoid arthritis patients. Arhritis Rheum 43 (2000) 2776-2784
9. Sambrook P.N., Eisman J.A., Champion G.D., et al. Determinants of axial bone loss in rheumatoid rrthritis. Arthritis Rheum 30 (1987) 721-727
10. Madsen O.R., Sorensen O.H., and Egsmose C. Bone quality and bone mass as assessed by quantitative ultrasound and dual energy X-ray absorptiometry in women with rheumatoid arthritis: relationship with quadriceps strength. Ann Rheum Dis 61 (2002) 325-329
11. Hakkinen A., Sokka T., Kotaniemi A., et al. A randomized two year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity and bone mineral density in early rheumatoid arthritis. Arthritis Rheum 44 (2001) 515-522
12. Hansen M., Florescu A., Stoltenberg M., et al. Bone loss in rheumatoid arthritis. Influence of disease activity, duration of the disease, functional capacity and corticoid treatment. Scand J Rheumatol 25 (1996) 367-376
13. Als O.S., Gotfredsen A., Riis B., et al. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis?. Ann Rheum Dis 44 (1985) 406-411
14. Shawe D., Hesp R., Gumpel J.M., et al. Physical activity as a determinant of bone conservation in the radial diaphysis in rheumatoid arthritis. Ann Rheum Dis 52 (1993) 579-581
15. Sambrook P.N., Eisman J.A., Yeates M.G., et al. Osteoporosis in rheumatoid arthritis: safety of low-dose corticosteroids. Ann Rheum Dis 45 (1986) 950-953
16. Leboff M.S., Wade J.P., Mackowiak S., et al. Low-dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol 18 (1991) 339-344
17. Laan R.F.J.M., Van Riel P.L.C.M., Van Earning L.J.T.H., et al. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low-dose prednisolone therapy. Br J Rheumatol 31 (1992) 91-96
18. Hall G.M., Spector T.D., Griffin A.J., et al. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum 36 (1993) 1510-1516
19. Shibuya K., Hagino H., Morio Y., et al. Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. Clin Rheumatol 21 (2002) 150-158
20. Sambrook P., Raj A., Hunter D., et al. Osteoporosis with low-dose corticosteroids: contribution of underlying disease effects and discriminatory ability of ultrasound versus bone densitometry. J Rheumatol 28 (2001) 1063-1067
21. Lane N.E., Pressman A.R., Star V.L., et al. Rheumatoid arthritis and bone mineral density in elderly women. J Bone Min Res 20 (1995) 257-263
22. Van Staa T.P., Leufkens H.G.M., and Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Oteoporos Int 13 (2002) 777-787
23. Ton F.N., Gunawardene C., Lee H., et al. Effects of low-dose prednisone on bone metabolism. J Bone Min Res 20 (2005) 464-470
24. Di Munno O., Mazzantini M., Sinigaglia L., et al. Effect of low-dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional study. J Rheumatol 31 (2004) 1305-1309
25. Haugeberg G., Orstavik R.E., Uhlig T., et al. Bone loss in patients with rheumatoid arthritis. Arthritis Rheum 46 (2002) 1720-1728
26. Shenstone B.D., Mahmoud A., Woodward R., et al. Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol 33 (1994) 541-545
27. Gough A.K.S., Lilley J., Eyre S., et al. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344 (1994) 23-27
28. Kalla A.A., Meyers O.L., Chalton D., et al. Increased metacarpal bone mass following 18 months of slow-acting antirheumatic drugs for rheumatoid arthritis. Br J Rheumatol 30 (1991) 91-100
29. Dolan A.L., Moniz C., Abraha H., et al. Does active treatment of rheumatoid arthritis limit disease-associated bone loss?. Rheumatol 41 (2002) 1047-1051
30. Quinn M. The effect of TNF blockade on bone loss in early rheumatoid arthritis. Arthritis Rheum 46 Suppl (2002) S519
31. Sambrook P.N. The skeleton in rheumatoid arthritis: common mechanisms for bone erosion and osteoporosis?. J Rheumatol 27 (2000) 2541-2542
32. Lodder M.C., de Jong Z., Kostense P.J., et al. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 63 (2004) 1576-1580
33. Forsblad d'Elia H., Larsen A., Waltbrand E., et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 62 (2003) 617-623
34. Forslind K., Keller C., Svensson B., et al. Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after two years in women. J Rheumatol 30 (2003) 2590-2596
35. Gough A., Sambrook P.N., Devlin J., et al. Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis. J Rheumatol 25 (1998) 1282-1289
36. Garnero P., Landewé R., Boers M., et al. Association of baseline levels of markers of bone and cartilage degradation with long-term progression of joint damage in patients with early rheumatoid arthritis. Arthritis Rheum 46 (2002) 2847-2856
37. Lodder M.C., Haugeberg G., Lems W.F., et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) Collaborative Study. Arthritis Rheum 49 (2003) 209-215
38. Hooyman J.R., Melton L.J., Nelson A.M., et al. Fractures after rheumatoid arthritis: a population-based study. Arthritis Rheum 27 (1984) 1353-1361
39. Peel N.F.A., Moore D.J., Barrington N.A., Bax D.E., and Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated Rheumatoid Arthritis. Ann Rheum Dis 54 (1995) 801-806
40. Orstavik R.E., Haugeberg G., Mowinckel P., et al. Vertebral deformities in rheumatoid arthritis. Arch Intern Med 164 (2004) 420-425
41. Cooper C., Coupland C., and Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 54 (1995) 49-52
42. Huusko T.M., Korpela M., Karppi P., et al. Threefold increased risk of hip fractures with rheumatoid arthritis in central Finland. Ann Rheum Dis 60 (2001) 521-522
43. Orstavik R.E., Haugeberg G., Uhlig T., et al. Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis 63 (2004) 177-182
44. Michel B.A., Bloch D., Wolfe F., et al. Fractures in rheumatoid arthritis: an evaluation of associated risk factor. J Rheumatol 20 (1993) 1666-1669
45. Orstavik R.E., Haugeberg G., Uhlig T., et al. Vertebral deformities in 229 female patients with Rheumatoid Arthritis: associations with clinical variables and bone mineral density. Arthritis Rheum 49 (2003) 355-360
46. Kaz Kaz H., Johnson D., Kerry S., et al. Fall-related risk factors and osteoporosis in women with rheumatoid arthritis. Rheumatol 43 (2004) 1267-1271
47. Jamison M., Neuberger G.B., and Miller P.A. Correlates of falls and fear of falling among adults with rheumatoid arthritis. Arthritis Rheum 49 (2003) 673-680
48. Haugeberg G., Orstavik R.E., Uhlig T., et al. Clinical decision rules in rheumatoid arthritis: do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register. Ann Rheum Dis 61 (2002) 1085-1089
49. Sinigaglia L, Varenna M, Binelli L, et al. Bone mass in systemic lupus erythematosus. Clin Exp Rheumatol 2000;18(Suppl 2)19:S27-34.
50. Dhillon V.B., Davies M.C., Hall M.L., et al. Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X ray absorptiometry. Ann Rheum Dis 49 (1990) 624-626
51. Houssiau F.A., Lefebvre C., Depresseux G., et al. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 35 (1996) 244-247
52. Sels F., Dequeker J., Verwilghen J., et al. SLE and osteoporosis: dependence and/or independence on glucocorticoids. Lupus 5 (1996) 89-92
53. Kalla A.A., Fataar A.B., Jessop S.J., et al. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 12 (1993) 1726-1734
54. Formiga F., Moga I., Nolla J.M., et al. Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 54 (1995) 274-276
55. Li E.K., Tam L.S., Young R.P., et al. Loss of bone mineral density in Chinese premenopausal women with systemic lupus erythematosus treated with corticosteroids. Br J Rheumatol 37 (1998) 405-410
56. Pineau C.A., Urowitz M.B., Fortin D., et al. Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus 13 (2004) 436-441
57. Lee C., Alamagor A., Dunlop D.D., et al. Disease damage and low bone mineral density: an analysis of women with systemic lupus erythematosus ever and never receiving corticosteroids. Rheumatol 45 (2006) 53-60
58. Pons F., Peris P., Guanabens N., et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women. Br J Rheumatol 34 (1995) 742-746
59. Kipen Y., Buchbinder R., Strauss B.J.G., et al. Prevalence of reduced bone mineral density in systemic lupus arythematosus and the role of glucocorticoids. J Rheumatol 24 (1997) 1922-1929
60. Sinigaglia L., Varenna M., Binelli L., et al. Determinants of bone mass in systemic lupus erythematosus: a cross-sectional study on premenopausal women. J Rheumatol 26 (1999) 1280-1284
61. Yee C.-S., Crabtree N., Skan J., et al. Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64 (2005) 111-113
62. Uaratanawong S., Deesomchoke U., Lertmaharit S., et al. Bone mineral density in premenopausal women with systemic lupus erythematosus. J Rheumatol 30 (2003) 2365-2368
63. Lilleby V., Lien G., Froslie K.F., et al. Frequency of osteopenia in children and young adults with childhood-onset systemic lupus erythematosus. Arthritis Rheum 52 (2005) 2051-2059
64. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res 8 (1995) 137-145
65. Mok C.C., Mak A., and Ma K.M. Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus. Lupus 14 (2005) 106-112
66. Formiga F., Nolla J.M., Moga I., et al. Sequential study of bone mineral density in patients with systemic lupus erythematosus. [letter]. Ann Rheum Dis 55 (1996) 857
67. Hansen M., Halberg P., Kollerup G., et al. Bone metabolism in patients with systemic lupus erythematosus. Scand J Rheumatol 27 (1998) 197-206
68. Kipen Y., Briganti E., Strauss B., et al. Three year follow up of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 26 (1999) 310-317
69. Trapani S., Civinini R., Ermini M., et al. Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effects of steroids on bone mineral density. Rheumatol Int 18 (1998) 45-49
70. Teichmann J., Lange U., Stracke H., et al. Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 18 (1999) 137-140
71. Formiga F., Nolla J.M., Mitjavila F., et al. Bone mineral density and hormonal status in men with systemic lupus erythematosus. Lupus 5 (1996) 623-626
72. Bultink I.E.M., Lems W.F., Kostense P.J., et al. Prevalence and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 54 (2005) 2044-2050
73. Borba V.Z.C., Matos P.G., Da Silva Viana P.R., et al. High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14 (2005) 529-533
74. Ramsey-Goldman R., Dunn J.E., Huang C.F., et al. Frequency of fractures in women with systemic lupus erythematosus. Arthritis Rheum 42 (1999) 882-890
75. Hanson C.A., Shagrin J.W., and Duncan H. Vertebral osteoporosis in ankylosing spondylitis. Clin Orthop 74 (1971) 59-64
76. Spencer D.G., Park W.M., Dick H.M., et al. Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheumatol 6 (1979) 305-315
77. Will R., Palmer R., Bhalla A.K., et al. Osteoporosis in early ankylosing spondylitis: a primary event?. Lancet 2 (1989) 1483-1485
78. Donnelly S., Doyle D.V., Denton A., et al. Bone mineral density and vertebral compression fracture rates in ankylosing spondylitis. Ann Rheum Dis 53 (1994) 117-121
79. Mitra D., Elvins D.M., Speden D.J., et al. The prevalence of vertebral fractures in mild ankylosing spondylitis and their relationship to bone mineral density. Rheumatol 39 (2000) 85-89
80. Lee L.Y.S., Schlotzhauer T., Ott S.M., et al. Skeletal status of men with early and late ankylosing spondylitis. Am J Med 103 (1997) 233-241
81. Bronson W.D., Walker S.E., Hillman L.S., et al. Bone mineral density and biochemical markers of bone metabolism in ankylosing spondylitis. J Rheumatol 25 (1998) 929-935
82. Reid D.M., Nicoll J.J., Kennedy N.S., et al. Bone mass in ankylosing spondylitis. J Rheumatol 13 (1986) 932-935
83. Mullaji A.B., Upadhyay S.S., and Ho E.K. Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg Br 76 (1994) 660-665
84. Devogelaer J.-P., Maldague B., Malghem J., et al. Appendicular and vertebral bone mass in ankylosing spondylitis. Arthritis Rheum 35 (1992) 1062-1067
85. Lange U., Kluge A., Strunk J., et al. Ankylosing spondylitis and bone mineral density. What is the ideal tool for measurement?. Rheumatol Int 26 2 (2005) 115-120
86. Karberg K., Zochling J., Sieper J., et al. Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32 (2005) 1290-1298
87. Gilgil E., Kacar C., Tuncer T., et al. The association of syndesmophytes with vertebral bone mineral density in patients with ankylosing spondylitis. J Rheumatol 32 (2005) 292-294
88. Toussirot E., Michel F., and Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatol 40 (2001) 882-888
89. Juanola X., Mateo L., Nolla J.-M., et al. Bone mineral density in women with ankylosing spondylitis. J Rheumatol 27 (2000) 1028-1031
90. Speden D.J., Calin A.I., Ring F.J., et al. Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis. J Rheumatol 29 (2002) 516-521
91. Grisar J., Bernecker P.M., Aringer M., et al. Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. J Rheumatol 29 (2002) 1430-1436
92. Gratacos J., Collado A., Pons F., et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis. Arthritis Rheum 42 (1999) 2319-2324
93. Maillefert J.F., Aho L.S., El Maghraoui A., et al. Changes in bone density in patients with ankylosing spondylitis: a two-year follow-up study. Osteoporos Int 12 (2001) 605-609
94. El Maghraoui A., Borderie D., Cherruau B., et al. Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26 (1999) 2205-2209
95. Cooper C., Carbone L., Michet C.J., et al. Fracture risk in patients with ankylosing spondylitis: a population based study. J Rheumatol 21 (1994) 1877-1882
96. Ralston S.H., Urquhart G.D.K., Brzeski M., et al. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ 300 (1990) 563-565
97. Thorngren K.G., Liedberg E., and Aspelin P. Fractures of the thoracic and lumbar spine in ankylosing spondylitis. Arch Orthop Traumat Surg 98 (1981) 101-107
98. Murray G.C., and Persellin R.H. Cervical fracture complicating in ankylosing spondylitis: a report of eight cases and review of the literature. Am J Med 70 (1981) 1033-1041
99. Grisolia A., Bell R., and Peltier L. Fractures and dislocations of the spine complicating ankylosing spondylitis. J Bone Joint Surg Am 49 (1967) 339-344
100. Sivri A., Killinc S., Gökce-Kutsal Y., et al. Bone mineral density in ankylosing spondylitis. Clin Rheumatol 15 (1996) 51-54
101. Baek H.J., Kang S.W., Lee J.Y., et al. Osteopenia in men with mild and severe ankylosing spondylitis. Rheumatol Int 26 (2005) 30-34
102. Mok C.C., Lau C.S., and Wong R.W.S. Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy. Arthritis Rheum 41 (1998) 831-837
103. Di Munno O., Mazzantini M., Massei P., et al. Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14 (1995) 407-412
104. Da Silva H.C., Szejnfeld V.L., Assis L.S., et al. Study of bone density in systemic scleroderma. Rev Assoc Med Bras 43 (1997) 40-46
105. Neuman K., Wallace K., and Metzger A. Osteoporosis. Less than expected in patients with scleroderma. J Rheumatol 27 (2000) 1822-1823
106. Frediani B., Baldi F., Falsetti P., et al. Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis. Clin Exp Rheum 22 (2004) 313-318
107. Sampaio-Barros P.D., Costa-Paiva L., Filardi S., et al. Prognostic factors of low bone mineral density in systemic sclerosis. Clin Exp Rheum 23 (2005) 180-184
108. Istok R., Czirjak L., Lukac J., et al. Increased urinary pyridinoline cross-link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon. Rheumatology (Oxford) 40 (2001) 140-146
109. Wright V. Psoriatic arthritis: a comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis. Ann Rheum Dis 20 (1961) 123-131
110. Harrison B.J., Hutchinson C.E., Adams J., et al. Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis. Ann Rheum Dis 61 (2002) 1007-1011
111. Nolla J.M., Rozadilla A., Gomez-Vaquero C., et al. Bone mineral density in patients with peripheral psoriatic arthritis. Rev Rhum Engl Ed 66 (1999) 457-461
112. Frediani B., Allegri A., Falsetti P., et al. Bone mineral density in patients with psoriatic arthritis. J Rheumatol 28 (2001) 138-143
113. Dolan A.L., Moniz C., Dasgupta B., et al. Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica. Arthritis Rheum 40 (1997) 2022-2029
114. Pearce G., Ryan P.F.J., Delmas P.D., et al. The deleterious effects of low-dose corticosteroids on bone density in patients with polymyalgia rheumatica. Br J Rheumatol 37 (1998) 292-299
115. Foss M.V.L., and Byers P.D. Bone density, osteoarthrosis of the hip and fracture of the upper end of the femur. Ann Rheum Dis 31 (1972) 259-264
116. Jones G., Nguyen T., Sambrook P.N., et al. A longitudinal study of the effect of spinal degenerative disease on bone density in the elderly. J Rheumatol 22 (1995) 932-936
117. Liu G., Peacock M., Eilam O., et al. Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women. Osteoporos Int 7 (1997) 564-569
118. Dequeker J., Goris P., and Uytterhoeven R. Osteoporosis and osteoarthritis (osteoarthrosis). Anthropometric distinctions. JAMA 249 (1983) 1448-1451
119. Dequeker J., Boonen S., Aerssens J., et al. Inverse relationship osteoarthritis-osteoporosis: what is the evidence? What are the consequences?. Br J Rheumatol 35 9 (1996) 813-818
120. Hart D., Mootoosamy I., Doyle D., et al. The relationship between osteoarthritis and osteoporosis in the general population: the Chingford Study. Ann Rheum Dis 53 (1994) 158-162
121. Nevitt M., Lane N., Scott J., et al. Radiographic osteoarthritis of the hip and bone mineral density. Arthritis Rheum 38 (1995) 907-916
122. Hannan M.T., Anderson J.J., Zhang Y., et al. Bone mineral density and knee osteoarthritis in elderly men and women. Arthritis Rheum 36 (1993) 1671-1680
123. Belmonte-Serrano M.A., Bloch A., Lane N.E., et al. The relationship between spinal and peripheral osteoarthritis and bone density measurements. J Rheumatol 20 (1993) 1005-1013
124. Marcelli C., Favier F., Kotzki P., et al. The relationship between osteoarthritis of the hands, bone mineral density, and osteoporotic fractures in elderly women. Osteoporos Int 5 (1995) 382-388
125. Burger H., van Daele P.L.A., Odding E., et al. Association of radiographically evident osteoarthritis with higher bone mineral density and increased bone loss with age: the Rotterdam Study. Arthritis Rheum 39 (1996) 81-86
126. Antoniades L., MacGregor A.J., Matson M., et al. A cotwin control study of the relationship between hip osteoarthritis and bone mineral density. Arthritis Rheum 43 (2000) 1450-1455
127. Hochberg M., Lethbridge-Cejku M., Scott W., et al. Appendicular bone mass and osteoarthritis of the hands in women: Data from the Baltimore Longitudinal Study of Aging. J Rheumatol 21 (1994) 1532-1536
128. Sowers M., Zobel D., Weissfeld L., et al. Progression of osteoarthritis of the hand and metacarpal bone loss. A twenty-year followup of incident cases. Arthritis Rheum 34 (1991) 36-42
129. Schneider D.L., Barrett-Connor E., Morton D.J., et al. Bone mineral density and clinical hand osteoarthritis in elderly men and women: The Rancho Bernardo Study. J Rheumatol 29 (2002) 1467-1472
130. Dequeker J., and Johnell O. Osteoarthritis protects against femoral neck fracture: the MEDOS study experience. Bone 14 Suppl 1 (1993) S51-S56
131. Cumming R.G., and Klineberg R.J. Epidemiological study of the relation between arthritis of the hip and hip fractures. Ann Rheum Dis 52 (1993) 707-710
132. Jones G., Nguyen T., Sambrook P.N., et al. Osteoarthritis, bone density, postural stability, and osteoporotic fractures: a population based study. J Rheumatol 22 (1995) 921-925
133. Arden N.K., Griffiths G.O., Hart D.J., et al. The association between osteoarthritis and osteoporotic fracture: the Chingford Study. Br J Rheumatol 35 (1996) 1299-1304
134. Arden N.K., Nevitt M.C., Lane N.E., et al. Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Arthritis Rheum 42 (1999) 1378-1385
135. Zhang Y., Hannan M.T., Chaisson C.E., et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. J Rheumatol 27 (2000) 1032-1037
136. Hart D.J., Cronin C., Daniels M., et al. The relationship of bone density and fracture to incident and progressive radiographic osteoarthritis of the knee: the Chingford Study. Arthritis Rheum 46 (2002) 92-99
137. Sornay-Rendu E., Munoz F., Duboeuf F., et al. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY study. J Bone Miner Res 19 (2004) 1994-1999
138. Bergink A.P., Van der Klift M., Hofman A., et al. Osteoarthritis of the knee is associated with vertebral and nonvertebral fractures in the elderly: the Rotterdam Study. Arthritis Rheum 49 (2003) 648-657
139. Naganathan V., Zochling J., March L., et al. Peak bone mass is increased in the hip in daughters of women with osteoarthritis. Bone 30 (2002) 287-292
140. Sambrook P., and Naganathan V. What is the relationship between osteoarthritis and osteoporosis?. Baillieres Clin Rheumatol 11 (1997) 695-710
141. Gilertson E.M. Development of periarticular osteophytes in experimentally induced osteoarthritis in the dog. A study using microradiographic, microangiographic, and fluorescent bone-labelling techniques. Ann Rheum Dis 34 (1975) 12-25
142. Radin E.L., and Rose R.M. Role of subchondral bone in the initiation and progression of cartilage damage. Clin Orthop Relat Res 213 (1986) 34-40
143. Dequeker J., Mohan S., Finkelman R.D., et al. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 36 (1993) 1702-1708
144. Uchino M., Izumi T., Tominaga T., et al. Growth factor expression in the osteophytes of the human femoral head in osteoarthritis. Clin Orthop Relat Res 377 (2000) 119-125